Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Fuji
US Department of Justice
US Army
Cerilliant
Medtronic
Dow
Julphar
Citi

Generated: November 14, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Urelumab

« Back to Dashboard

US Patents for Urelumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Urelumab ➤ Sign Up P97 fragments with transfer activity biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Sign Up
Urelumab ➤ Sign Up Meditopes and meditope-binding antibodies and uses thereof City of Hope (Duarte, CA) ➤ Sign Up
Urelumab ➤ Sign Up Fragments of p97 and uses thereof biOasis Technologies, Inc. (Richmond, CA) ➤ Sign Up
Urelumab ➤ Sign Up Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Sign Up
Urelumab ➤ Sign Up Compounds and compositions for immunotherapy BIRDIE BIOPHARMACEUTICALS, INC. (Grand Cayman, KY) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Urelumab

Drugname Country Document Number Estimated Expiration Related US Patent
Urelumab Australia 2012294673 2031-08-05 ➤ Sign Up
Urelumab Canada 2842492 2031-08-05 ➤ Sign Up
Urelumab Denmark 2739649 2031-08-05 ➤ Sign Up
Urelumab European Patent Office 2739649 2031-08-05 ➤ Sign Up
Urelumab European Patent Office 3321281 2031-08-05 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
Cipla
Healthtrust
Teva
Queensland Health
Moodys
Dow
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.